Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$20.98 - $31.42 $1.19 Million - $1.78 Million
56,786 Added 89.83%
120,000 $2.59 Million
Q1 2023

May 15, 2023

BUY
$27.71 - $40.93 $348,536 - $514,817
12,578 Added 24.84%
63,214 $1.85 Million
Q4 2022

Feb 14, 2023

SELL
$29.75 - $39.26 $11.3 Million - $14.9 Million
-378,700 Reduced 88.21%
50,636 $1.87 Million
Q3 2022

Nov 14, 2022

BUY
$17.15 - $30.92 $7.36 Million - $13.3 Million
429,336 New
429,336 $12.1 Million

Others Institutions Holding AMLX

About Amylyx Pharmaceuticals, Inc.


  • Ticker AMLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,533,200
  • Market Cap $290M
  • Description
  • Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...
More about AMLX
Track This Portfolio

Track Soleus Capital Management, L.P. Portfolio

Follow Soleus Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Soleus Capital Management, L.P. with notifications on news.